IMDX logo

IMDX
Insight Molecular Diagnostics Inc.

3,661
Mkt Cap
$105.51M
Volume
274,153.00
52W High
$8.51
52W Low
$2.33
PE Ratio
-2.13
IMDX Fundamentals
Price
$3.44
Prev Close
$3.28
Open
$3.03
50D MA
$5.45
Beta
0.61
Avg. Volume
206,147.98
EPS (Annual)
-$1.65
P/B
-3.14
Rev/Employee
$69,913.79
$219.76
Loading...
Loading...
News
all
press releases
Oncocyte (NASDAQ:IMDX) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen lowered shares of Oncocyte from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Oncocyte (NASDAQ:IMDX) Price Target Raised to $12.00
Lake Street Capital boosted their price target on shares of Oncocyte from $8.00 to $12.00 and gave the stock a "buy" rating in a research note on Tuesday...
MarketBeat·1mo ago
News Placeholder
Insider Buying: Oncocyte (NASDAQ:IMDX) Major Shareholder Acquires 521,739 Shares of Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. bought 521,739 shares of Oncocyte stock in a transaction that occurred on Tuesday, February 10th. The stock...
MarketBeat·2mo ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Trading 9.4% Higher - What's Next?
Oncocyte (NASDAQ:IMDX) Shares Up 9.4% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Shares Down 3.4% - Should You Sell?
Oncocyte (NASDAQ:IMDX) Trading Down 3.4% - Here's What Happened...
MarketBeat·3mo ago
News Placeholder
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Zacks·9mo ago
<
...
1
>

Latest IMDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.